戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 roliferation of allospecific CD8+ T cells in mixed lymphocyte culture.
2 BALB/c (H-2(d)) host spleen cells in a 5-day mixed lymphocyte culture.
3 , and in their ability to suppress a one-way mixed lymphocyte culture.
4  development of T cell hyporesponsiveness in mixed lymphocyte culture.
5 on to C57BL/6 splenocyte stimulator cells in mixed lymphocyte culture.
6 gglutinin, monoclonal antibodies to CD3, and mixed lymphocyte culture.
7 optive transfer assay and in vitro coculture mixed lymphocyte culture.
8  IFN-gamma-producing responses in allogeneic mixed lymphocyte cultures.
9 the generation of cytolytic T lymphocytes in mixed lymphocyte cultures.
10 ine-dependent cytotoxic T-cell generation in mixed lymphocyte cultures.
11  pairs based upon molecular tissue typing or mixed lymphocyte cultures.
12  not generate cytotoxic responses in primary mixed-lymphocyte cultures against MHC-disparate (allogen
13 splant recipients 2 years postoperatively in mixed lymphocyte culture and cell-mediated lympholysis r
14 poresponsiveness of residual CD8+ T cells in mixed lymphocyte culture and cytotoxic T lymphocyte to L
15 cyte responsiveness was measured by in vitro mixed lymphocyte culture and cytotoxic T lymphocyte.
16 bustness of mixed chimerism was tested using mixed lymphocyte cultures and skin grafts.
17  absence of proliferation of CD4(+) T cells (mixed lymphocyte culture) and the description of an aber
18  were followed by inspection, serial biopsy, mixed lymphocyte culture, and alloantibody determination
19 also potently suppressed when evaluated in a mixed lymphocyte culture assay.
20 hese compounds showed inhibitory activity in mixed lymphocyte culture assay.
21  demonstrated nonspecific suppression of the mixed lymphocyte culture assays at 90 and 200 days and a
22                                              Mixed lymphocyte culture assays demonstrated T cell tole
23                                              Mixed lymphocyte culture assays showed a trend toward a
24 utatively tolerant animals was examined with mixed lymphocyte cultures, cell-mediated lympholysis ass
25 bset (26-76%) of CD8+ CTL generated in human mixed lymphocyte cultures; cell sorting experiments conf
26                                              Mixed lymphocyte cultures, cytotoxic assays, and precurs
27 responses to postnatal boosts) and in vitro (mixed lymphocyte culture, cytotoxicity, and cytokine rel
28 CD4+ T cells cultured in short-term in vitro mixed lymphocyte cultures developed strong Ag-specific c
29 response upon donor antigen restimulation in mixed lymphocyte cultures ex vivo.
30                 In vitro, GLAT inhibited the mixed lymphocyte culture in a dose-dependent fashion acr
31                                              Mixed lymphocytes cultured in the presence of two reagen
32                                     In vitro mixed lymphocyte culture (MLC) and cell-mediated lymphol
33 we tested two of the regulators for in vitro mixed lymphocyte culture (MLC) and cytotoxic T lymphocyt
34  myeloid cells, isolated from sex-mismatched mixed lymphocyte culture (MLC) nonreactive siblings, hav
35          Cell-mediated lympholysis (CML) and mixed lymphocyte culture (MLC) responses of peripheral b
36 nalloreactive T lymphocytes, by performing a mixed lymphocyte culture (MLC) stimulation of donor cell
37    Immunological responses were monitored by mixed lymphocyte culture (MLC), CML, skin graft rejectio
38 duction, as measured by in vitro analysis of mixed lymphocyte culture (MLC), T cell cytotoxicity, T h
39                      Four groups of outbred, mixed lymphocyte culture (MLC)-reactive pigs underwent b
40  this stimulatory activity of DBMC, in vitro mixed lymphocyte cultures (MLC) and cell-mediated lympho
41 ide was added either after the initiation of mixed lymphocyte cultures (MLC) or after interleukin-2 s
42         In addition, IFN-gamma production in mixed lymphocyte cultures (MLC) supplemented with IL-12
43 rum levels and decreased IL-12 production in mixed lymphocyte cultures (MLC).
44 on, we determined the role of IL-32 in human mixed lymphocyte cultures (MLCs) and GVHD.
45 cific hyporesponsiveness was first observed (mixed lymphocyte culture [(MLR]) on Day 48.
46 unophenotype profile, suppressive ability in mixed lymphocyte cultures, morphology, and ability to di
47 ning, using untreated bone marrow cells from mixed lymphocyte culture-nonreactive normal littermates.
48         Immunological hyporesponsiveness (by mixed lymphocyte culture) occurred more frequently in tr
49 ion by human T-cell populations generated in mixed lymphocyte cultures or isolated from transplant ne
50 ion inhibited donor-specific and third-party mixed lymphocyte culture proliferation in a dose-depende
51  kidney allografts that were incompatible in mixed lymphocyte culture reactions.
52                                              Mixed lymphocyte culture-reactive, outbred pigs underwen
53          Alloreactive CTLs from M3-specific, mixed lymphocyte cultures responded strongly against the
54 rvival was monitored daily from day 10, with mixed lymphocyte culture responses measured on day 14 or
55 cine had no effect on IL-2 production in the mixed lymphocyte culture; therefore, the effect of glyci
56     Immunocompetence was assessed by one-way mixed lymphocyte culture using patients' peripheral bloo
57                  When we added QMAD to human mixed lymphocyte cultures, we observed dose-dependent in
58                                              Mixed lymphocyte cultures were supplemented with transfo
59 ingle-peptide mice react strongly in primary mixed lymphocyte cultures with IAb molecules from wild-t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。